ICU Medical director receives 1,475 RSUs
ICU Medical director David F. Hoffmeister reported compensation-related equity activity.
Rhea-AI Filing Summary
ICU Medical director David F. Hoffmeister reported compensation-related equity activity. On May 13, 2026, he acquired 1,254 shares of Common Stock through the exercise of previously granted Restricted Stock Units, bringing his direct holdings to 6,004 shares of Common Stock.
On the same date, he also received a new award of 1,475 Restricted Stock Units. These RSUs have no purchase or exercise price and are scheduled to vest on the anniversary of the grant date or at the following annual stockholder meeting, whichever occurs first. The filing shows no open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,254 shares exercised/converted
Exercise
3 txns
Insider
Hoffmeister David F
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Stock | 1,254 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,475 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,254 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 1,475 contracts (Direct);
Common Stock — 6,004 shares (Direct)
Footnotes (3)
- F1. These securities are Restricted Stock Units.
- F2. There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- F3. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.
Key Figures
RSU shares exercised: 1,254 shares
Shares held after exercise: 6,004 shares
New RSU grant size: 1,475 RSUs
+2 more
5 metrics
RSU shares exercised
1,254 shares
Common Stock acquired via RSU exercise on May 13, 2026
Shares held after exercise
6,004 shares
Direct Common Stock holdings following RSU conversion
New RSU grant size
1,475 RSUs
Restricted Stock Units granted May 13, 2026
RSU exercise price
$0.00 per unit
No purchase or exercise price for Restricted Stock Units
RSU vesting/expiration date
May 13, 2027
Grant and expiration date for 1,475 RSUs
Key Terms
Restricted Stock Units, exercise or conversion of derivative security, grant, award, or other acquisition, annual stockholder meeting
4 terms
Restricted Stock Units financial
"These securities are Restricted Stock Units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
annual stockholder meeting financial
"vest on the anniversary of the date of the grant or the following annual stockholder meeting"
An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ICU Medical (ICUI) director David F. Hoffmeister report?
He reported acquiring 1,254 ICU Medical common shares via Restricted Stock Unit vesting and receiving a new grant of 1,475 RSUs. These transactions are compensation-related equity awards, not open-market stock purchases or sales, and increase his overall exposure to ICU Medical stock.
What is the size of the new RSU grant to the ICU Medical (ICUI) director?
He received a grant of 1,475 Restricted Stock Units tied to ICU Medical common stock. These RSUs carry no purchase or exercise price and represent a stock-based compensation award that will convert into shares once they vest under the award’s stated schedule.
When do the newly granted ICU Medical (ICUI) RSUs vest for the director?
The RSUs vest on the anniversary of the grant date or at the following annual stockholder meeting, whichever occurs first. This schedule means vesting is tied to the company’s governance calendar rather than performance targets or multi-year service conditions.
Is there any exercise price for the ICU Medical (ICUI) Restricted Stock Units reported?
The filing states there is neither a purchase price nor an exercise price for the Restricted Stock Units. When they vest, they convert into ICU Medical common shares without the director paying cash, functioning as share-based compensation rather than traditional stock options.
Does this ICU Medical (ICUI) Form 4 show any open-market stock sales or purchases?
No, the transactions are an RSU-based share acquisition and a new RSU grant, both at a stated price of $0.00 per unit. The report shows no open-market buying or selling activity, only compensation-related equity movements for the director on May 13, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
